Sanguine
Cyrus M. serves as Chief Executive Officer at both NovaCina and LumaCina, leading organizations dedicated to providing high-quality sterile injectable drug products and essential hospital drugs globally. With extensive experience in the pharmaceutical and biotechnology sectors, Cyrus M. is also the Chairman and Managing Partner at Bioselective Capital Investments and holds advisory roles at Advent International and Bridgewest Ventures NZ. Previous leadership positions include President and Chief Executive Officer at BioDuro-Sundia and Formex, LLC, and Vice Chairman and Chief Executive Officer at Molecular Response. Cyrus M. possesses a Bachelor of Science in Biology from UC Irvine and has been instrumental in the growth and development of numerous companies within the industry.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Sanguine
4 followers
Sanguine Biosciences is a pioneer of in-home specimen collection and a leader in direct-to-patient recruitment and digital health innovation. They partner with researchers on their study designs and support cross-sectional and longitudinal analyses with complex patient inclusion/exclusion sample collection criteria.